Short answer
OMNICELL, INC. (OMCL) filed its fiscal 2025 10-K annual report with the SEC on Feb 26, 2026. It reported revenue of $1.2B (+6.5% year over year) and net income of $2M.
- Top risk flagged: Regulatory risk under privacy and data protection laws with potential compliance cost and liability exposure
FY2025 key financial metrics · XBRL
- Revenue
- $1.2B
- +6.5% YoY
- Net income
- $2M
- −83.6% YoY
- Operating margin
- 0.4%
- +0.4 pp YoY
- Gross margin
- 42.5%
- +0.1 pp YoY
- EPS (diluted)
- $0.04
- −85.2% YoY
- ROE
- 0.2%
- −0.8 pp YoY
- Operating cash flow
- $127M
- −32.2% YoY
Source: XBRL data from the OMNICELL, INC. (OMCL) FY2025 10-K on SEC EDGAR. USD.
OMNICELL, INC. FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business model: medication management solutions and adherence tools primarily for healthcare systems and pharmacies in the U.S. market
- No new product lines or segments introduced; company continues managing as a single operating and reporting segment
- Strategic focus remains on integrated hardware, software, and services contracts with emphasis on identifying distinct performance obligations for revenue recognition
- Revenue $1.185B, up 6.5% YoY driven by product revenues $665.7M (+5.6%) and service revenues $519.1M (+7.8%)
- Noteworthy: net income sharply decreased to $2.1M from $12.5M in prior year, reflecting narrowed operating income $5.2M vs $0.3M prior and ongoing investment in R&D ($88.7M)
Management Discussion & Analysis
- Revenue $1.185B in 2025, up $72.6M or 7% YoY from $1.112B in 2024; product revenues $665.7M (+6%), service revenues $519.1M (+8%)
- ARR $636M in 2025, up from $580M in 2024; product bookings $535M in 2025, down from $558M in 2024
- Operating segment: Single reporting segment; best performing area includes XTExtend product revenue growth; worst impacted includes XT Series dispensing systems due to lifecycle timing and Central Pharmacy Dispensing Service product revenue decline
- No segment-level profitability or margin % given; CODM evaluates consolidated net income (loss)
- Forward outlook: Anticipates healthcare fiscal headwinds including $910B Medicaid cut, rising tariffs, and labor shortages pressuring margins; expects shift to flexible payment models (leasing, subscriptions) and investment in pharmacy automation and analytics
Risk Factors
- Regulatory risk under privacy and data protection laws with potential compliance cost and liability exposure
- Cybersecurity disruption risk involving information system breaches impacting business operations
- Third-party service provider dependency creating information security vulnerabilities from cloud and cybersecurity vendors
- Key-person risk from reliance on Chief Information Security Officer with 20+ years experience overseeing cybersecurity
- Audit Committee oversight risk with reliance on post-incident remediation and monitoring to mitigate cybersecurity incidents
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.